Prescription Details for Cequa: Discover its form, potency, usage instructions, and additional information
In a significant development for those suffering from dry eye syndrome, the Food and Drug Administration (FDA) has approved Cequa (cyclosporine ophthalmic solution) for long-term treatment of the condition. This prescription drug, used twice daily, increases tear production in adults with dry eye syndrome (keratoconjunctivitis sicca).
Cequa comes as an eye drop solution in single-use vials, each containing 0.25 milliliters (mL) of solution. The strength of Cequa is 0.09% cyclosporine, which equates to 0.9 milligrams (mg) of cyclosporine per mL of solution.
When using Cequa, it's essential to follow a few guidelines to ensure safe and effective use. After using the solution in both eyes, dispose of the vial safely. Do not save or reuse the vial for a future dose, even if there's some solution left inside. It's also important to note that if you wear contact lenses, you should remove them before using Cequa and wait 15 minutes before reinserting them.
While the long-term side effects of Cequa are primarily limited to local eye irritation and discomfort, it's crucial to be aware of potential side effects. Common local side effects include eye pain after instillation, eye redness, eye irritation, and eyelid inflammation. Other reported side effects, although less frequent, include headache and urinary tract infection.
It's important to note that Cequa, as an eye drop, is associated mostly with local side effects in the eyes rather than systemic toxicity. This is in contrast to systemic cyclosporine (oral or injection form), which can cause more severe side effects including kidney dysfunction, high blood pressure, increased infection risk, and is a known carcinogen. These effects do not apply to topical eye drop formulations like Cequa.
To help remember your doses, consider using a medication reminder, such as an alarm, note, or reminder app. If you experience any side effects that may prevent you from taking your medication, notify your doctor immediately. Lastly, do not let the tip of the vial touch your eye or any other surface.
In conclusion, the long-term side effects of Cequa are mainly limited to local eye irritation and discomfort, with no significant systemic toxicities reported with its ophthalmic use. However, patients should follow instructions carefully to avoid contamination and irritation. If new symptoms or serious eye problems occur, a patient should consult their healthcare provider promptly.
- The newly established treatment—Cequa, a 0.09% cyclosporine ophthalmic solution—has been approved by the FDA for seekers suffering from dry eye syndrome (keratoconjunctivitis sicca).
- Deciders considering this prescription drug for long-term treatment should be aware that it increases tear production in affected adults, with each single-use vial containing 0.25 mL of solution.
- After using Cequa in both eyes, switchers should dispose of the vial safely and refrain from saving or reusing it, even if there's some solution left.
- Persons using Cequa must adhere to strict guidelines to ensure safe and effective use, including removing contact lenses before application and allowing 15 minutes to pass before reinsertion.
- When using Cequa, some eye side effects may occur, such as eye pain, redness, irritation, and eyelid inflammation, and it's important to notify treaters if these persist or become severe.
- Although Cequa, a health-and-wellness product designed for the eyes, mainly causes local side effects, mental-health issues like kidney dysfunction, high blood pressure, increased infection risk, and carcinogenicity are associated with systemic cyclosporine (oral or injection form).
